vs
PROVIDENT FINANCIAL HOLDINGS INC(PROV)与SUTRO BIOPHARMA, INC.(STRO)财务数据对比。点击上方公司名可切换其他公司
SUTRO BIOPHARMA, INC.的季度营收约是PROVIDENT FINANCIAL HOLDINGS INC的1.2倍($11.6M vs $9.8M),PROVIDENT FINANCIAL HOLDINGS INC同比增速更快(2.5% vs -21.4%),过去两年PROVIDENT FINANCIAL HOLDINGS INC的营收复合增速更高(2.3% vs -5.4%)
普罗维登特金融控股公司是一家银行控股企业,通过旗下全资子公司普罗维登特储蓄银行开展业务,为美国加利福尼亚州当地社区提供各类存款、住房抵押贷款、消费贷款、小微企业融资等零售及商业金融服务。
Sutro Biopharma是一家上市生物科技公司,总部位于加州南旧金山,专注于临床阶段药物的研发、开发与生产。公司依托自主专有的无细胞蛋白质合成平台,结合蛋白质工程与理性设计技术开发肿瘤治疗药物。公司2003年成立时名为Fundamental Applied Biology,2009年改用现名。
PROV vs STRO — 直观对比
营收规模更大
STRO
是对方的1.2倍
$9.8M
营收增速更快
PROV
高出23.8%
-21.4%
两年增速更快
PROV
近两年复合增速
-5.4%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $9.8M | $11.6M |
| 净利润 | $1.4M | — |
| 毛利率 | — | — |
| 营业利润率 | 20.8% | — |
| 净利率 | 14.6% | — |
| 营收同比 | 2.5% | -21.4% |
| 净利润同比 | 64.7% | 35.4% |
| 每股收益(稀释后) | $0.22 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
PROV
STRO
| Q4 25 | $9.8M | $11.6M | ||
| Q3 25 | $9.7M | $9.7M | ||
| Q2 25 | $9.8M | $63.7M | ||
| Q1 25 | $10.1M | $17.4M | ||
| Q4 24 | $9.6M | $14.8M | ||
| Q3 24 | $9.5M | $8.5M | ||
| Q2 24 | $9.9M | $25.7M | ||
| Q1 24 | $9.4M | $13.0M |
净利润
PROV
STRO
| Q4 25 | $1.4M | — | ||
| Q3 25 | $1.7M | $-56.9M | ||
| Q2 25 | $1.6M | $-11.5M | ||
| Q1 25 | $1.9M | $-76.0M | ||
| Q4 24 | $872.0K | $-72.4M | ||
| Q3 24 | $1.9M | $-48.8M | ||
| Q2 24 | $2.0M | $-48.0M | ||
| Q1 24 | $1.5M | $-58.2M |
营业利润率
PROV
STRO
| Q4 25 | 20.8% | — | ||
| Q3 25 | 28.1% | -499.9% | ||
| Q2 25 | 23.6% | -5.2% | ||
| Q1 25 | 26.2% | -393.8% | ||
| Q4 24 | 12.7% | -440.7% | ||
| Q3 24 | 28.3% | -797.2% | ||
| Q2 24 | 27.8% | -189.4% | ||
| Q1 24 | 22.5% | -435.0% |
净利率
PROV
STRO
| Q4 25 | 14.6% | — | ||
| Q3 25 | 17.3% | -586.6% | ||
| Q2 25 | 16.7% | -18.0% | ||
| Q1 25 | 18.4% | -436.6% | ||
| Q4 24 | 9.1% | -489.2% | ||
| Q3 24 | 20.0% | -572.6% | ||
| Q2 24 | 19.7% | -186.8% | ||
| Q1 24 | 15.9% | -447.5% |
每股收益(稀释后)
PROV
STRO
| Q4 25 | $0.22 | — | ||
| Q3 25 | $0.25 | $-0.67 | ||
| Q2 25 | $0.24 | $-0.14 | ||
| Q1 25 | $0.28 | $-0.91 | ||
| Q4 24 | $0.13 | $-27.63 | ||
| Q3 24 | $0.28 | $-0.59 | ||
| Q2 24 | $0.28 | $-0.59 | ||
| Q1 24 | $0.22 | $-0.59 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $54.4M | $141.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $127.5M | $-132.5M |
| 总资产 | $1.2B | $173.8M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
PROV
STRO
| Q4 25 | $54.4M | $141.4M | ||
| Q3 25 | $49.4M | $167.6M | ||
| Q2 25 | $53.1M | $205.1M | ||
| Q1 25 | $50.9M | $249.0M | ||
| Q4 24 | $45.5M | $316.9M | ||
| Q3 24 | $48.2M | $388.3M | ||
| Q2 24 | $51.4M | $375.6M | ||
| Q1 24 | $51.7M | $267.6M |
股东权益
PROV
STRO
| Q4 25 | $127.5M | $-132.5M | ||
| Q3 25 | $128.4M | $-87.3M | ||
| Q2 25 | $128.5M | $-32.1M | ||
| Q1 25 | $128.9M | $-25.8M | ||
| Q4 24 | $128.6M | $44.6M | ||
| Q3 24 | $129.6M | $111.2M | ||
| Q2 24 | $129.9M | $152.2M | ||
| Q1 24 | $129.5M | $98.0M |
总资产
PROV
STRO
| Q4 25 | $1.2B | $173.8M | ||
| Q3 25 | $1.2B | $209.7M | ||
| Q2 25 | $1.2B | $262.4M | ||
| Q1 25 | $1.3B | $321.4M | ||
| Q4 24 | $1.3B | $387.2M | ||
| Q3 24 | $1.3B | $451.8M | ||
| Q2 24 | $1.3B | $489.0M | ||
| Q1 24 | $1.3B | $403.4M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $1.2M | $-177.2M |
| 自由现金流经营现金流 - 资本支出 | $1.0M | — |
| 自由现金流率自由现金流/营收 | 10.5% | — |
| 资本支出强度资本支出/营收 | 1.9% | — |
| 现金转化率经营现金流/净利润 | 0.85× | — |
| 过去12个月自由现金流最近4个季度 | $14.9M | — |
8季度趋势,按日历期对齐
经营现金流
PROV
STRO
| Q4 25 | $1.2M | $-177.2M | ||
| Q3 25 | $2.5M | $-38.2M | ||
| Q2 25 | $8.7M | $-44.7M | ||
| Q1 25 | $3.3M | $-67.9M | ||
| Q4 24 | $324.0K | $-71.7M | ||
| Q3 24 | $2.6M | $-64.5M | ||
| Q2 24 | $5.7M | $9.5M | ||
| Q1 24 | $3.0M | $-64.7M |
自由现金流
PROV
STRO
| Q4 25 | $1.0M | — | ||
| Q3 25 | $2.5M | — | ||
| Q2 25 | $8.2M | — | ||
| Q1 25 | $3.3M | — | ||
| Q4 24 | $307.0K | — | ||
| Q3 24 | $2.4M | — | ||
| Q2 24 | $4.1M | — | ||
| Q1 24 | $2.6M | — |
自由现金流率
PROV
STRO
| Q4 25 | 10.5% | — | ||
| Q3 25 | 25.2% | — | ||
| Q2 25 | 83.5% | — | ||
| Q1 25 | 32.5% | — | ||
| Q4 24 | 3.2% | — | ||
| Q3 24 | 25.1% | — | ||
| Q2 24 | 41.3% | — | ||
| Q1 24 | 27.5% | — |
资本支出强度
PROV
STRO
| Q4 25 | 1.9% | — | ||
| Q3 25 | 0.5% | — | ||
| Q2 25 | 5.4% | — | ||
| Q1 25 | 0.3% | — | ||
| Q4 24 | 0.2% | — | ||
| Q3 24 | 1.8% | — | ||
| Q2 24 | 16.0% | — | ||
| Q1 24 | 4.2% | — |
现金转化率
PROV
STRO
| Q4 25 | 0.85× | — | ||
| Q3 25 | 1.48× | — | ||
| Q2 25 | 5.34× | — | ||
| Q1 25 | 1.79× | — | ||
| Q4 24 | 0.37× | — | ||
| Q3 24 | 1.35× | — | ||
| Q2 24 | 2.91× | — | ||
| Q1 24 | 2.00× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图